Le Lézard
Classified in: Health, Science and technology
Subject: AWD

ISI Technology Makes Inc. 5000 List for the Second Consecutive Year


BUFFALO, N.Y., Sept. 20, 2024 /PRNewswire/ -- ISI Technology, a leading provider of software solutions for Non-Emergency Medical Transportation (NEMT) and Medicaid billing, is thrilled to announce that it has been named to the prestigious Inc. 5000 list for the second year in a row. The Inc. 5000 ranks the fastest-growing privately-held companies in the United States, and ISI Technology's inclusion in this elite group underscores its continued success, innovation, and impact on the NEMT industry.

Being recognized two years in a row by Inc. 5000 highlights ISI Technology's rapid growth, driven by its commitment to delivering cutting-edge software that streamlines NEMT operations for providers worldwide. ISI Technology's software solutions empower providers with advanced scheduling, real-time tracking, and automated billing, allowing them to offer more efficient and reliable transportation services.

"This achievement reflects the hard work of our team, the loyalty of our clients, and our shared commitment to innovation," said Jonathon Anthon, Chief Executive Officer of ISI Technology. "Making the Inc. 5000 list for the second consecutive year is a significant milestone that speaks to our sustained growth and our dedication to improving healthcare accessibility through technology. We're incredibly proud of this honor and look forward to continuing our journey of success."

ISI Technology's placement on the Inc. 5000 list demonstrates not only its financial growth but also its lasting influence in the NEMT sector, providing transformative solutions that help providers optimize their operations while enhancing patient care.

For more information about ISI Technology and its recognition on the Inc. 5000 list, please visit isi-technology.com or contact [email protected].

About ISI Technology: ISI Technology is a leader in Non-Emergency Medical Transportation (NEMT) and Medicaid billing software solutions. Dedicated to innovation and customer satisfaction, ISI Technology provides NEMT providers with advanced tools to optimize their operations, improve service quality, and enhance healthcare accessibility.

Media Contact:
Yurii Martynov
+1 716-220-8663
[email protected]

SOURCE ISI Technology


These press releases may also interest you

at 14:24
HealthCentral Wins Top Honors at MM&M Awards for Consumer, Professional Brands
HealthCentral, a leading digital health platform serving patients living with chronic and serious illness, has taken top honors at the 2024 Medical Marketing and Media (MM+M) Awards, winning the Gold Award for Healthcare Consumer Media Brand for an...

at 14:18
Pharmaceutical Filtration Industry Forecasts $18.1 Billion Market Size by 2029
"According to the latest BCC Research study, the demand for "Pharmaceutical Filtration: Global Markets" is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029." The...

at 14:18
Rhinoplasty Expert Dr. Shervin Naderi Selected Again for Washingtonian Top Doctors 2024 List
The Naderi Center is pleased to announce that Dr. Shervin Naderi has been named a 2024 Washingtonian Top Doctor, highlighting Dr. Naderi's expertise in rhinoplasty, aesthetic injections, and exceptional patient care. The list is compiled through peer...

at 14:09
Fastest Growing Company in Massachusetts Honored as 2024 BostInno Fire Award Honoree
On the heels of World Mental Health Day, Uwill, the leading mental health and wellness solution, announced its recognition as a 2024 BostInno Fire Award Honoree. The recognition highlights fast-growing companies in the Boston area that are...

at 13:41
Inaugural class of Wound Care Champions to be honoured at Wounds Canada National Conference
Wounds Canada and the Registered Nurses' Association of Ontario (RNAO) have partnered to develop and deliver the Wound Care Champion Program for regulated health-care providers. Through this program, which has been generously funded by the Ontario...

at 13:33
FDA Approves New Treatment for Hemophilia A or B
Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without...

More news about Health...


News published on and distributed by: